Insulong Spp

Insulong SPP: Review of intermediate-acting insulin

Insulong SPP is a drug used to treat diabetes mellitus. It belongs to the group of intermediate-acting insulins and is produced by the Croatian company Pliva. In this article we will look at the main characteristics and properties of Insulong SPP.

Country of origin and pharmaceutical group
Insulong SPP is produced in Croatia by the company Pliva. It belongs to the group of intermediate-acting insulins. This type of insulin is designed to keep blood glucose levels stable for a longer period of time.

International name and synonyms
The international name of Insulong SPP is Insulin-SrD. It is also known by various synonyms, including B-Insulin Berlin-Chemie, Berlinsulin N Basal U-40, Berlinsulin N Basal pen, Biogulin NPH U-100, Biogulin NPH U-40, Biogulin Lente U-40, Brinsulmidi MK, Brinsulmidi Ch , Brinsulmidi ChSP, V-Insulin SC Berlin-Chemie, Depo-Insulin S, Isofan Insulin and Isofan Insulin.

Dosage forms
Insulong SPP is presented in the form of an injection suspension with a concentration of 40 U/ml. This means that each milliliter of suspension contains 40 units of insulin. This form makes it easier to administer the drug to patients who require regular insulin administration.

Insulong SPP is intended for injection under the skin and is usually used once or twice a day, depending on the individual needs of the patient. It provides stable action over a longer period of time compared to short-acting insulins, which allows you to control blood glucose levels throughout the day.

It is important to note that Insulong SPP should only be used as prescribed by a doctor. The dosage and regimen of insulin should be individually adjusted for each patient, based on his needs and characteristics of the disease.

In conclusion, Insulong SPP is an intermediate-acting insulin manufactured in Croatia by the company Pliva. It provides stable blood glucose levels for a longer period of time and is important. Insulong SPP: Intermediate Acting Insulin Review

Insulong SPP is an intermediate-acting insulin produced by Pliva in Croatia. It belongs to the pharmaceutical group of intermediate-acting insulins intended for the treatment of diabetes mellitus. In this article we will look at the main characteristics and forms of Insulong SPP, as well as its international name and synonyms.

Country of origin and pharmaceutical group
Insulong SPP is manufactured by Pliva, which is based in Croatia. It belongs to the group of intermediate-acting insulins. This type of insulin is designed to keep blood glucose levels stable for a longer period of time.

International name and synonyms
The international name of Insulong SPP is Insulin-SrD. It also has several synonyms, including B-Insulin Berlin-Chemie, Berlinsulin N Basal U-40, Berlinsulin N Basal pen, Biogulin NPH U-100, Biogulin NPH U-40, Biogulin Lente U-40, Brinsulmidi MK, Brinsulmidi Ch, Brinsulmidi ChSP, V-Insulin SC Berlin-Chemie, Depo-Insulin S, Isofan Insulin and Isofan Insulin.

Dosage forms
Insulong SPP is presented in the form of an injection suspension with a concentration of 40 U/ml. This means that each milliliter of suspension contains 40 units of insulin. Providing insulin in suspension form simplifies its administration to patients who need to receive insulin regularly.

Insulong SPP is usually administered subcutaneously to patients once or twice daily, depending on individual needs and physician recommendations. It provides stable action over a longer period of time compared to short-acting insulins, which allows you to control blood glucose levels over a long period of time.

It is important to note that Insulong SPP should only be used as prescribed by a doctor. The dosage and regimen of insulin use must be individually adjusted for each patient, taking into account his needs and characteristics of the disease.

In conclusion, Insulong SPP is an intermediate-acting insulin manufactured in Croatia by the company Pliva.